UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027392
Receipt number R000031316
Scientific Title Study on the effects of hydroxyapatite (HA) and artificial bone prosthesis made of beta-TCP in implant treatment (randomized controlled trial)
Date of disclosure of the study information 2017/05/31
Last modified on 2019/11/19 19:14:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the effects of hydroxyapatite (HA) and artificial bone prosthesis made of beta-TCP in implant treatment (randomized controlled trial)

Acronym

Study on the effects of artificial bone prosthesis (HA and beta-TCP) in implant treatment

Scientific Title

Study on the effects of hydroxyapatite (HA) and artificial bone prosthesis made of beta-TCP in implant treatment (randomized controlled trial)

Scientific Title:Acronym

Study on the effects of artificial bone prosthesis (HA and beta-TCP) in implant treatment

Region

Japan


Condition

Condition

patients with bone defect

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To estimate the effects of artificial bone prosthesis for bone augmentation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

survival rate after one year of the dental implant placed in the augmented bone

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Duration:1 year
Bone formation using cerasorb or Arrowbone beta dental at the same time as the dental implant placement or 2nd term is performed and bone level is confirmed by dental radiograph 1 year after implant placement.

Interventions/Control_2

Duration:1 year
Bone formation using neobone at the same time as the dental implant placement or 2nd term is performed and bone level is confirmed by dental radiograph 1 year after implant placement.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients with albeolar bone defect

Key exclusion criteria

patient with poor general condition

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Fumio
Middle name
Last name Suehiro

Organization

Graduate School of Medical and Dental Sciences, Kagoshima University

Division name

Department of Oral and Maxillofacial Prosthodontics

Zip code

8908544

Address

8-35-1 Sakuragaoka, Kagoshima 890-8544

TEL

099-275-6222

Email

fsuehiro@dent.kagoshima-u.ac.jp


Public contact

Name of contact person

1st name Fumio
Middle name
Last name Suehiro

Organization

Graduate School of Medical and Dental Sciences, Kagoshima University

Division name

Department of Oral and Maxillofacial Prosthodontics

Zip code

8908544

Address

8-35-1 Sakuragaoka, Kagoshima 890-8544

TEL

099-275-6222

Homepage URL


Email

fsuehiro@dent.kagoshima-u.ac.jp


Sponsor or person

Institute

Graduate School of Medical and Dental Sciences, Kagoshima University

Institute

Department

Personal name



Funding Source

Organization

Kagoshima University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagoshima University hospital, Division of clinical trial

Address

8-35-1 Sakuragaoka, Kagoshima 890-8544

Tel

0992755553

Email

crmc@m2.kufm.kagoshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

9

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 09 Day

Date of IRB

2016 Year 12 Month 05 Day

Anticipated trial start date

2017 Year 05 Month 31 Day

Last follow-up date

2018 Year 12 Month 27 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 05 Month 18 Day

Last modified on

2019 Year 11 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031316


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name